Shareholders meeting

GlaxoSmithKline Pharmaceuticals Limited GSK House, Dr. Annie Besant Road, Worli, Mumbai - 400 030 Tel No: +91 22 2495 9595 Fax No: +91 22 2495 9494 Web: www.gsk-india.com Email: askus@gsk.com 30th June 2026 BSE LIMITED THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1, G Block Dalal Street Bandra-Kurla Complex, Bandra (East) Mumbai - 400001 Mumbai - 400051 Dear Sirs, Re: Regulation 44 (3) of Listing Obligations and disclosure Requirement Regulations, 2015 (“LODR”) Sub: Disclosure of Voting Results and Outcome of the 101st Annual General Meeting of the Company In compliance with the provisions of the Companies Act, 2013 (‘Act‘), Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations‘) and the General Circulars issued by Ministry of Corporate Affairs, dated May 5, 2020 read with circulars dated April 8, 2020 and April 13, 2020 and other subsequent circulars, the latest being and other subsequent 22nd September 2025 (collectively referred to as “MCA Circulars”)and SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the 101st Annual General Meeting of the Company held today i.e. on Tuesday, 30th June 2026 at 11.00 a.m. through Video Conferencing or Other Audio-Visual Means (OAVM) and concluded at 01.00 p.m. without the physical presence of the Members at a common venue. In Compliance with the provisions of Regulations 44(3) of the LODR, Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management & Administration) Rules 2014 as amended, the Company had provided voting facility to all its members to enable them to cast their vote on all matters listed in the Notice convening the Annual General Meeting through electronic means (remote e-voting) during the period commencing from Friday, 26th June 2026 (9.00 a.m.) to Monday, 29th June 2026 (5.00 p.m.). The Company had also provided voting facility through e-voting to the members present during the Annual General Meeting and who had not cast their vote earlier through remote e-voting facility. We wish to inform you that all the resolutions contained in the Notice of the Annual General Meeting dated 13th May 2026 were approved by the Members. In this Connection, please find enclosed the following: A) Details regarding the brief proceedings of the Annual General Meeting (AGM) of the Company pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. B) Details regarding the voting results of the business transacted at the said AGM in the prescribed format pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. C) Consolidated Report of the Scrutinizer on remote e-voting and e-voting conducted during the AGM. Details regarding the voting results of the business transacted at the said AGM in the prescribed format pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are also being submitted in the prescribed format. The voting results along with the Scrutinizer’s Report is available on the Company’s website at www.gsk-india.com and is also being made available on the website of the National Securities Depository Limited at www.evoting.nsdl.com You are requested to take note of the same and bring it to the notice of all concerned. Thanking you, Yours faithfully For GlaxoSmithKline Pharmaceuticals Limited Ajay Nadkarni Vice President – Administration, Real Estate & Company Secretary Encl: CIN: L24239MH1924PLC001151 Brief details of the items deliberated at the annual general meeting held on Tuesday, 30th June 2026 and the results Sr Agenda Resolution Mode of Voting Results no required 1 To receive, consider and adopt the Ordinary Remote E-voting Passed with Audited Financial Statements and E-voting requisite (including Consolidated Financial during the AGM majority Statements) of the Company for the financial year ended 31st March 2026, together with the Reports of the Board of Directors and Auditors thereon 2 To declare Dividend of Rs. 57 per Ordinary Remote E-voting Passed with share on Equity Shares for the and E-voting requisite financial year ended 31st March 2026. during the AGM majority 3 To appoint a Director, in place of Mr. Ordinary Remote E-voting Passed with Subesh Williams (DIN: 07786724), and E-voting requisite who retires by rotation and being during the AGM majority eligible, offers himself for re-appointment. 4 Commission to Independent Directors Special Remote E-voting Passed with and E-voting requisite during the AGM majority 5 Ratification of Remuneration to Cost Ordinary Remote E-voting Passed with Auditor for Financial Year ended 31st and E-voting requisite March 2026 during the AGM majority 6 Ratification of Remuneration to Cost Ordinary Remote E-voting Passed with Auditor for Financial Year ended 31st and E-voting requisite March 2027 during the AGM majority (cid:3) GLAXOSMITHKLINE PHARMACEUTICALS LIMITED GSK House, Dr. Annie Besant Road, Worli, Mumbai - 400 030 Dear Sir, Sub: Consolidated Scrutinizer’s Report on remote e-voting conducted prior to the 101st Annual General Meeting of GlaxoSmithKline Pharmaceuticals Limited(cid:3)held on Tuesday, June 30, 2026 at 11:00 a.m. (IST) through video conferencing (‘VC’)/other audio visual means (‘OAVM’) and remote e-voting conducted during the AGM, pursuant to the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended by the Companies (Management and Administration) Amendment Rules, 2015 and Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) I, P. N. Parikh, of Parikh & Associates, Practising Company Secretaries, had been appointed as the Scrutinizer by the Board of Directors of GlaxoSmithKline Pharmaceuticals Limited (“the Company”) pursuant to Section 108 of the Companies Act, 2013 (“the Act”) read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended, to conduct & scrutinize the remote e- voting process in respect of the below mentioned resolutions passed at the 101st Annual General Meeting (“AGM”) of the Company held on Tuesday, June 30, 2026 at 11:00 a.m. (IST) through VC/OAVM. I was also appointed as Scrutinizer to scrutinize the remote e-voting process during the said AGM. The Notice dated May 13, 2026, convening the 101st AGM, as confirmed by the Company was sent, in respect of the below mentioned resolutions passed at the AGM of the Company through electronic mode, to those Members whose email addresses are registered with the Company/Depositories, in compliance with the Circulars issued by the Ministry of Corporate Affairs dated April 8, 2020, April 13, 2020, May 5, 2020, and subsequent circulars issued in this regard, the latest being dated September 22, 2025 (collectively referred to as “MCA Circulars”) and Regulation 36(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) unless any Member has requested for a physical copy of the same. The Company has also sent a letter to shareholders providing the web-link and QR code for accessing the Integrated Annual Report 2025-2026 to those Members who have not registered their e-mail address with the Company/Registrar and Share Transfer Agent/Depositories, in compliance with Regulation 36(1)(b) of SEBI Listing Regulations. The Company had availed the e-voting facility offered by National Securities Depository Limited (‘NSDL’) for conducting remote e-voting before and during the AGM by the shareholders of the Company. The voting period for remote e-voting commenced on Friday, June 26, 2026 at 09:00 a.m. (IST) and ended on Monday, June 29, 2026 at 05:00 p.m. (IST) and the NSDL e-vo [Showing first 8,000 characters — download PDF for full document]